Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.

1. This study further examines the quinoline-derivative abanoquil with particular respect to the duration of its alpha 1-adrenoceptor antagonist activity and its concentration-effect relationship following a single intravenous bolus dose of 0.5 micrograms kg-1 in young, normotensive males. 2. alpha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Schafers, R F, Elliott, H L, Meredith, P A, Miller, S H, Reid, J L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1991
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1368638/
https://ncbi.nlm.nih.gov/pubmed/1683250
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak